These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 3531110

  • 1. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study.
    Nelson DF, Diener-West M, Weinstein AS, Schoenfeld D, Nelson JS, Sause WT, Chang CH, Goodman R, Carabell S.
    Int J Radiat Oncol Biol Phys; 1986 Oct; 12(10):1793-800. PubMed ID: 3531110
    [Abstract] [Full Text] [Related]

  • 2. A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery; preliminary results of an RTOG study.
    Nelson DF, Schoenfeld D, Weinstein AS, Nelson JS, Wasserman T, Goodman RL, Carabell S.
    Int J Radiat Oncol Biol Phys; 1983 Aug; 9(8):1143-51. PubMed ID: 6347995
    [Abstract] [Full Text] [Related]

  • 3. Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma.
    Deutsch M, Green SB, Strike TA, Burger PC, Robertson JT, Selker RG, Shapiro WR, Mealey J, Ransohoff J, Paoletti P.
    Int J Radiat Oncol Biol Phys; 1989 Jun; 16(6):1389-96. PubMed ID: 2542193
    [Abstract] [Full Text] [Related]

  • 4. Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16?
    Nelson DF, Gillespie BW, Diener MD, Davis DR, Wasserman T, Phillips TL, Stetz J.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1731-4. PubMed ID: 6384162
    [Abstract] [Full Text] [Related]

  • 5. Misonidazole combined with hyperfractionation in the management of malignant glioma.
    Fulton DS, Urtasun RC, Shin KH, Geggie PH, Thomas H, Muller PJ, Moody J, Tanasichuk H, Mielke B, Johnson E.
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1709-12. PubMed ID: 6090367
    [Abstract] [Full Text] [Related]

  • 6. Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. A joint Radiation Therapy Oncology Group and Eastern Cooperative Oncology Group study.
    Chang CH, Horton J, Schoenfeld D, Salazer O, Perez-Tamayo R, Kramer S, Weinstein A, Nelson JS, Tsukada Y.
    Cancer; 1983 Sep 15; 52(6):997-1007. PubMed ID: 6349785
    [Abstract] [Full Text] [Related]

  • 7. An analysis of radiotherapy data from the CNS cancer consortium's randomized prospective trial comparing AZQ to BCNU in the treatment of patients with primary malignant brain tumors. The CNS cancer consortium.
    Halperin EC, Gaspar L, Imperato J, Salter M, Herndon J, Dowling S.
    Am J Clin Oncol; 1993 Aug 15; 16(4):277-83. PubMed ID: 8392285
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary toxicity of carmustine in patients treated for malignant glioma.
    Weinstein AS, Diener-West M, Nelson DF, Pakuris E.
    Cancer Treat Rep; 1986 Aug 15; 70(8):943-6. PubMed ID: 3524837
    [Abstract] [Full Text] [Related]

  • 9. Phase I evaluation of radiation combined with recombinant interferon alpha-2a and BCNU for patients with high-grade glioma.
    Rajkumar SV, Buckner JC, Schomberg PJ, Cascino TL, Burch PA, Dinapoli RP.
    Int J Radiat Oncol Biol Phys; 1998 Jan 15; 40(2):297-302. PubMed ID: 9457812
    [Abstract] [Full Text] [Related]

  • 10. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H, Ewend MG, Piantadosi S, Greenhoot J, Burger PC, Sisti M.
    J Neurooncol; 1995 Nov 15; 26(2):111-23. PubMed ID: 8787853
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial.
    Walker MD, Alexander E, Hunt WE, MacCarty CS, Mahaley MS, Mealey J, Norrell HA, Owens G, Ransohoff J, Wilson CB, Gehan EA, Strike TA.
    J Neurosurg; 1978 Sep 15; 49(3):333-43. PubMed ID: 355604
    [Abstract] [Full Text] [Related]

  • 12. The Brain Tumor Cooperative Group NIH Trial 87-01: a randomized comparison of surgery, external radiotherapy, and carmustine versus surgery, interstitial radiotherapy boost, external radiation therapy, and carmustine.
    Selker RG, Shapiro WR, Burger P, Blackwood MS, Arena VC, Gilder JC, Malkin MG, Mealey JJ, Neal JH, Olson J, Robertson JT, Barnett GH, Bloomfield S, Albright R, Hochberg FH, Hiesiger E, Green S, Brain Tumor Cooperative Group.
    Neurosurgery; 2002 Aug 15; 51(2):343-55; discussion 355-7. PubMed ID: 12182772
    [Abstract] [Full Text] [Related]

  • 13. Phase I evaluation of preirradiation chemotherapy with carmustine and cisplatin and accelerated radiation therapy in patients with high-grade gliomas.
    Rajkumar SV, Buckner JC, Schomberg PJ, Pitot HC, Ingle JN, Cascino TL.
    Neurosurgery; 1999 Jan 15; 44(1):67-73. PubMed ID: 9894965
    [Abstract] [Full Text] [Related]

  • 14. Combined modality approach to treatment of malignant gliomas--re-evaluation of RTOG 7401/ECOG 1374 with long-term follow-up: a joint study of the Radiation Therapy Oncology Group and the Eastern Cooperative Oncology Group.
    Nelson DF, Diener-West M, Horton J, Chang CH, Schoenfeld D, Nelson JS.
    NCI Monogr; 1988 Jan 15; (6):279-84. PubMed ID: 3281031
    [Abstract] [Full Text] [Related]

  • 15. A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02.
    Curran WJ, Scott CB, Nelson JS, Weinstein AS, Phillips TL, Murray K, Fischbach AJ, Yakar D, Schwade JG, Powlis WD.
    Cancer; 1992 Dec 15; 70(12):2909-17. PubMed ID: 1451073
    [Abstract] [Full Text] [Related]

  • 16. NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients.
    Ali AN, Zhang P, Yung WKA, Chen Y, Movsas B, Urtasun RC, Jones CU, Choi KN, Michalski JM, Fischbach AJ, Markoe AM, Schultz CJ, Penas-Prado M, Garg MK, Hartford AC, Kim HE, Won M, Curran WJ.
    J Neurooncol; 2018 Mar 15; 137(1):39-47. PubMed ID: 29404979
    [Abstract] [Full Text] [Related]

  • 17. A phase III comparison of BCNU, hydroxyurea, and radiation therapy to BCNU and radiation therapy for treatment of primary malignant gliomas.
    Levin VA, Wilson CB, Davis R, Wara WM, Pischer TL, Irwin L.
    J Neurosurg; 1979 Oct 15; 51(4):526-32. PubMed ID: 225456
    [No Abstract] [Full Text] [Related]

  • 18. Prolongation of survival for high-grade malignant gliomas with adjuvant high-dose BCNU and autologous bone marrow transplantation.
    Johnson DB, Thompson JM, Corwin JA, Mosley KR, Smith MT, de los Reyes RA, Daly MB, Petty AM, Lamaster D, Pierson WP.
    J Clin Oncol; 1987 May 15; 5(5):783-9. PubMed ID: 3553437
    [Abstract] [Full Text] [Related]

  • 19. Large fraction irradiation with or without misonidazole in advanced non-oat cell carcinoma of the lung: a phase III randomized trial of the RTOG. Radiation Therapy Oncology Group.
    Simpson JR, Bauer M, Wasserman TH, Perez CA, Emami B, Wiegensberg I, Zinninger M, Durbin LM.
    Int J Radiat Oncol Biol Phys; 1987 Jun 15; 13(6):861-7. PubMed ID: 3034841
    [Abstract] [Full Text] [Related]

  • 20. Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study.
    Hochberg F, Prados M, Russell C, Weissman D, Evans R, Cook P, Burton G, Eisenberg PD, Valenzuela R, Verkh L.
    J Neurooncol; 1997 Mar 15; 32(1):45-55. PubMed ID: 9049862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.